Financials U.S. NeuroSurgical Holdings, Inc.
Equities
USNU
US90336K1016
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 USD | -12.86% | -15.28% | +35.56% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 1.636 | 1.558 | 2.104 | 1.792 | 0.8626 | 4.178 |
Enterprise Value (EV) 1 | 2.504 | 1.355 | 0.2689 | -0.3198 | -0.6514 | 3.797 |
P/E ratio | -3.89 x | 11 x | 3.95 x | -2.86 x | -0.65 x | -5.12 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.48 x | 0.51 x | 0.66 x | 1.69 x | - | - |
EV / Revenue | 0.73 x | 0.44 x | 0.08 x | -0.3 x | - | - |
EV / EBITDA | 1.39 x | 0.54 x | - | - | - | - |
EV / FCF | -2.98 x | 0.58 x | 0.28 x | -0.36 x | 0.72 x | -21.8 x |
FCF Yield | -33.6% | 171% | 363% | -279% | 140% | -4.59% |
Price to Book | 0.54 x | 0.49 x | 0.57 x | 0.63 x | 0.7 x | 6.48 x |
Nbr of stocks (in thousands) | 7,792 | 7,792 | 7,792 | 7,792 | 7,842 | 9,285 |
Reference price 2 | 0.2100 | 0.2000 | 0.2700 | 0.2300 | 0.1100 | 0.4500 |
Announcement Date | 4/11/19 | 4/13/20 | 4/7/21 | 4/15/22 | 4/13/23 | 4/5/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 3.424 | 3.07 | 3.173 | 1.061 | - | - |
EBITDA 1 | 1.797 | 2.493 | - | - | - | - |
EBIT 1 | 0.794 | 1.49 | 1.615 | -0.089 | -1.071 | -0.765 |
Operating Margin | 23.19% | 48.53% | 50.9% | -8.39% | - | - |
Earnings before Tax (EBT) 1 | -0.613 | 0.151 | 0.856 | -0.554 | -1.533 | -0.816 |
Net income 1 | -0.421 | 0.142 | 0.533 | -0.627 | -1.337 | -0.816 |
Net margin | -12.3% | 4.63% | 16.8% | -59.1% | - | - |
EPS 2 | -0.0540 | 0.0182 | 0.0684 | -0.0805 | -0.1705 | -0.0879 |
Free Cash Flow 1 | -0.8404 | 2.322 | 0.9768 | 0.8925 | -0.9094 | -0.1744 |
FCF margin | -24.54% | 75.65% | 30.78% | 84.12% | - | - |
FCF Conversion (EBITDA) | - | 93.16% | - | - | - | - |
FCF Conversion (Net income) | - | 1,635.48% | 183.26% | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/11/19 | 4/13/20 | 4/7/21 | 4/15/22 | 4/13/23 | 4/5/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.87 | - | - | - | - | - |
Net Cash position 1 | - | 0.2 | 1.84 | 2.11 | 1.51 | 0.38 |
Leverage (Debt/EBITDA) | 0.483 x | - | - | - | - | - |
Free Cash Flow 1 | -0.84 | 2.32 | 0.98 | 0.89 | -0.91 | -0.17 |
ROE (net income / shareholders' equity) | -13.1% | 4.61% | 15.6% | -19.2% | -70.1% | -77.7% |
ROA (Net income/ Total Assets) | 7.03% | 16.6% | 22% | -1.42% | -24.6% | -31.2% |
Assets 1 | -5.989 | 0.8541 | 2.421 | 44.3 | 5.428 | 2.618 |
Book Value Per Share 2 | 0.3900 | 0.4000 | 0.4700 | 0.3600 | 0.1600 | 0.0700 |
Cash Flow per Share 2 | 0.1900 | 0.1700 | 0.2600 | 0.2800 | 0.2000 | 0.0500 |
Capex 1 | 0.57 | - | - | - | - | - |
Capex / Sales | 16.65% | - | - | - | - | - |
Announcement Date | 4/11/19 | 4/13/20 | 4/7/21 | 4/15/22 | 4/13/23 | 4/5/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+35.56% | 8.23M | |
+17.30% | 83.16B | |
-26.28% | 73.08B | |
-1.34% | 26.15B | |
+4.06% | 17.9B | |
-9.26% | 17.39B | |
+4.08% | 15.94B | |
+76.90% | 13.61B | |
+76.96% | 13.06B | |
-25.61% | 12.76B |
- Stock Market
- Equities
- USNU Stock
- Financials U.S. NeuroSurgical Holdings, Inc.